Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis

Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis

Ami Vyas,1 Meghan Gabriel,2 Sobha Kurian3 1Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA; 2Pharmacy Quality Alliance, Alexandria, VA, USA; 3West Virginia University, School of Medicine, Morgantown, WV, USACorrespondence: Ami VyasDepartment of Pha...

Full description

Bibliographic Details
Main Authors: Vyas A, Gabriel M, Kurian S
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:Breast Cancer : Targets and Therapy
Subjects:
guideline-concordant treatment
decomposition
her2-negative
breast cancer
seer-medicare database
Online Access:https://www.dovepress.com/disparities-in-guideline-concordant-initial-systemic-treatment-in-wome-peer-reviewed-article-BCTT

Internet

https://www.dovepress.com/disparities-in-guideline-concordant-initial-systemic-treatment-in-wome-peer-reviewed-article-BCTT

Similar Items